NeuroXT
PrivateLast Round
Series A
Mar 10, 2025
Company Overview
NeuroXT operates in Healthcare & Life Sciences and is based in Seoul. Its latest recorded funding round was a Series A round in March 2025.
NeuroXT is a biotechnology company that develops AI-driven neuroimaging biomarker solutions to predict treatment responses for Alzheimer's disease.
Sector
Healthcare & Life Sciences
Verticals
Medical Imaging, Medical AI, Precision Medicine, Biotechnology, Healthcare Analytics
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting, Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NeuroXT Comparables
Compare NeuroXT with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Qynapse | 83% | |
| Darmiyan | 82% | |
| Neurophet | 80% |
For institutional investors. Book with your work email.
NeuroXT Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Mar 10, 2025 | ||||
| Pre Seed | May 1, 2023 | ||||
| Seed | Jun 1, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
NeuroXT Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Smilegate Investment | Pre Seed, Series A |
| Kakao Ventures | Pre Seed |
| Korea Investment Accelerator | Pre Seed |
| Samsung Venture Investment | Series A |
| Mirae Ventures | Seed |
| LSK Investment | Series A |
| AJU IB Investment | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 18, 2026
Monthly visitors increased 50% MoM.
- May 17, 2026
Monthly visitors grew 269% MoM, reaching 1.2K.
For institutional investors. Book with your work email.
NeuroXT Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about NeuroXT's valuation, stock price, and market status.
Is NeuroXT a public or private company?
NeuroXT is a private company.
What is the current stock price of NeuroXT?
NeuroXT is a private company, so its shares have no public market price. Caplight tracks NeuroXT's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is NeuroXT worth (valuation)?
Valuation information for NeuroXT is not publicly available.
Can I buy NeuroXT stock?
NeuroXT shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was NeuroXT's last funding round?
NeuroXT's most recent funding round was Series A on March 10, 2025.
Who are the main investors in NeuroXT?
Key investors in NeuroXT include Smilegate Investment, Kakao Ventures, Korea Investment Accelerator, Samsung Venture Investment, Mirae Ventures.
Will NeuroXT IPO soon?
No public IPO plans have been announced for NeuroXT.
How can I track NeuroXT secondary market activity?
Caplight tracks bids, offers, and trades in NeuroXT's shares on secondary markets.